Related Experiment Videos
Projecting future drug expenditures--2005
James M Hoffman1, Nilay D Shah, Lee C Vermeulen
1Pharmaceutical Department, St. Jude Children's Research Hospital, Memphis, TN, USA.
Summary
Drug expenditure growth moderated in 2003 and early 2004 due to patent expirations and fewer new drug approvals. However, 2005 is projected to see accelerated drug spending across various healthcare settings.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Healthcare Management
Background:
- Drug expenditures represent a significant component of overall healthcare spending.
- Understanding trends in drug spending is crucial for healthcare policy and resource allocation.
- Previous years saw varying rates of increase in pharmaceutical costs.
Purpose of the Study:
- To analyze drug expenditure trends in the United States for 2003 and 2004.
- To project drug expenditures for the year 2005.
- To identify key factors influencing drug cost changes.
Main Methods:
- Analysis of historical drug expenditure data for 2003 and 2004.
- Review of factors influencing drug pricing and utilization.
- Projection modeling for 2005 drug spending.
Main Results:
- Drug expenditure growth slowed to 11.4% in 2003 and 8.7% in the first nine months of 2004.
- Factors contributing to moderation include patent expirations, generic drug availability, and fewer new drug approvals.
- Economic factors like consumer cost-sharing and employment levels also impacted utilization.
Conclusions:
- Projected drug expenditure growth for 2005 is expected to outpace overall healthcare and economic growth.
- Anticipated increases in drug spending for 2005 are 10-12% (outpatient), 12-15% (clinics), and 6-9% (hospitals).
- Future drug costs will be influenced by drug prices, pipeline of new drugs, and generic competition.